Der er rapporteret om nyudviklet diabetes mellitus, hyperglykæmi eller forværring af eksisterende diabetes mellitus hos patienter, der fik antiretroviral behandling inklusive proteasehæmmere.
New onset of diabetes mellitus, hyperglycaemia or exacerbations of existing diabetes mellitus have been reported in patients receiving antiretroviral therapy, including protease inhibitors.